Skip to content

Clinical trials

Memory Disorders trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Memory Disorders Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20041
20081
20141
20172
20181
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status2
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Erasmus Medical Center2
AbbVie1
Amsterdam UMC, location VUmc1
CHU de Quebec-Universite Laval1
Ionis Pharmaceuticals, Inc.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Klimmendaal Revalidatiespecialisten1
Lexicon Pharmaceuticals1
Maastricht University Medical Center1
Wageningen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Memory Disorders11
Cognitive Dysfunction7
Alzheimer Disease2
Attention Deficit Disorder with Hyperactivity2
Brain Injuries2
Dementia2
Neurocognitive Disorders2
Pick Disease of the Brain2
Atherosclerosis1
COVID-191

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.